E Fund Management (HK)’s United Therapeutics UTHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$23.8K Sell
44
-2
-4% -$1.03K 0.01% 350
2026
Q2
$24.9K Buy
46
+16
+53% +$9.01K 0.01% 269
2026
Q1
$17.8K Buy
+30
New +$14.9K 0.01% 217

Other funds holding UTHR

E Fund Management (HK)'s UTHR Position: Q3 2026 in Review

E Fund Management (HK) reduced its United Therapeutics (UTHR) stake by 4.3% in Q3 2026, selling an estimated $1.03K and leaving 44 shares worth $23.8K. The position accounts for 0.01% of the portfolio, ranked #350.

E Fund Management (HK) first reported a position in UTHR in Q1 2026 and has held it in 3 quarters since. The position peaked at $24.9K in Q2 2026. 846 funds tracked by Wall St. Rank hold UTHR as of Q3 2026.

  • E Fund Management (HK) held 44 shares of United Therapeutics worth $23.8K as of Q3 2026.
  • E Fund Management (HK) sold 2 United Therapeutics shares in Q3 2026, an estimated $1.03K.
  • United Therapeutics made up 0.01% of E Fund Management (HK)'s portfolio in Q3 2026, its #350 holding.
  • E Fund Management (HK) first reported a position in United Therapeutics in Q1 2026 and has held it in 3 quarters since.
  • E Fund Management (HK)'s United Therapeutics position peaked at $24.9K in Q2 2026.
  • 846 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2026.

Based on E Fund Management (HK)'s 13F filing for Q3 2026, filed 12 Nov 2026.